NEWRON PHARMACEUTICALS S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.28 CHF | +8.82% |
|
+4.75% | +47.07% |
| 17/04 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
| 19/03 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quotes 5-day view
Delayed Quote Swiss Exchange| 23/04/2024 | 24/04/2024 | 25/04/2024 | 26/04/2024 | |
|---|---|---|---|---|
| Last | 7 CHF | 7 CHF | 6.69 CHF | 7.28 CHF |
| Volume | 32 096 | 43 337 | 63 462 | 59 318 |
| Change | -2.51% | 0.00% | -4.43% | +8.82% |
| Opening | 7.29 | 7.18 | 6.93 | 6.71 |
| High | 7.29 | 7.18 | 6.93 | 7.29 |
| Low | 6.85 | 6.85 | 6.52 | 6.71 |
Performance
| 1 day | +8.82% | ||
| 1 week | +4.75% | ||
| Current month | -6.19% | ||
| 1 month | -2.67% | ||
| 3 months | -11.86% | ||
| 6 months | +54.89% | ||
| Current year | +47.07% | ||
| 1 year | +69.30% | ||
| 3 years | +192.37% | ||
| 5 years | -19.56% | ||
| 10 years | -52.11% |
Volumes
marketsDaily volume
58 174
Estimated daily volume
58 174
Avg. Volume 20 sessions
72 312
Daily volume ratio
0.80
Avg. Volume 20 sessions CHF
526 431.36
Avg. Volume 20 sessions USD
575 600.05
Record volume 1
2 869 218
Record volume 2
1 493 471
Record volume 3
1 445 697
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CHF)
138 685 717
Capitalization (USD)
148 285 542
Net sales (EUR)
9 057 000
Net sales (USD)
9 683 926
Number of employees
22
Sales / Employee (EUR)
411 682
Sales / Employee (USD)
440 178
Free-Float
91.61 %
Free-Float capitalization (CHF)
127 055 872
Free-Float capitalization (USD)
135 850 679
Average Daily Capital Traded
0.38%
Highs and lows
1 week
6.52
7.29
1 month
6.108.84
Current year
4.5711.45
1 year
3.7011.45
3 years
1.0111.45
5 years
0.9011.45
10 years
0.9035.85
Indicators
Moving average 5 days
7.03
Moving average 20 days
7.49
Moving average 50 days
7.82
Moving average 100 days
7.27
Price spread / (MMA5)
-3.43%
Price spread / (MMA20)
+2.88%
Price spread / (MMA50)
+7.39%
Price spread / (MMA100)
-0.17%
STIM
RSI 9 days
33.92
RSI 14 days
37.59
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +8.82% | +4.75% | +47.07% | +69.30% | 148M | ||
| -1.85% | +1.41% | -4.66% | -10.60% | 86.13B | ||
| -1.28% | -1.41% | +1.32% | -1.66% | 39.82B | ||
| +3.18% | +7.47% | -19.27% | -27.48% | 30.42B | ||
| +0.65% | +2.76% | +57.86% | +46.08% | 25.23B | ||
| -1.53% | -8.71% | -16.09% | -13.00% | 15.35B | ||
| +7.67% | +2.31% | -9.14% | -9.50% | 11.95B | ||
| +0.98% | -1.28% | -17.69% | -29.72% | 11.6B | ||
| +1.81% | -13.98% | -43.00% | -35.34% | 11.51B | ||
| +0.07% | +7.66% | +5.24% | +7.25% | 8.71B | ||
| +1.56% | +17.92% | -8.42% | +2.49% | 8.12B | ||
| +1.57% | +1.23% | +2.29% | +20.02% | 7.72B | ||
| 0.00% | +3.15% | +76.35% | +283.44% | 6.69B | ||
| -0.96% | +2.57% | -10.12% | +16.72% | 6.59B | ||
| -0.80% | -0.49% | -7.72% | +6.85% | 6.49B | ||
| +4.03% | +4.90% | -16.71% | -41.12% | 6.01B | ||
| Average | +1.49% | +1.77% | +2.33% | +17.73% | ||
| Weighted average by Cap. | +0.15% | +0.97% | -0.84% | +1.18% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
1f9250fe4090b.bJL82hbcBeVD7fB_8sz9bmWncP9bxGtbw9II7Gn8Z7w.JsOMjkeWT7Uar5gwuvnPCCrCOMoYpQc3rJZy3hnOV-UV67WZRo89sybcvQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 09:01:30 pm | 7.28 | 1 | 58,174 |
| 09:01:30 pm | 7.28 | 62 | 58,173 |
| 09:01:30 pm | 7.28 | 35 | 58,111 |
| 09:01:30 pm | 7.28 | 258 | 58,076 |
| 09:01:30 pm | 7.28 | 69 | 57,818 |
| 09:01:30 pm | 7.28 | 110 | 57,749 |
| 09:01:30 pm | 7.28 | 250 | 57,639 |
| 09:01:30 pm | 7.28 | 215 | 57,389 |
| 09:01:30 pm | 7.28 | 500 | 57,174 |
| 09:01:30 pm | 7.28 | 109 | 56,674 |
Monthly variations
Annual change
| 2024 | +47.07% | ||
| 2023 | +219.35% | ||
| 2022 | -4.32% | ||
| 2021 | -24.65% | ||
| 2020 | -66.14% | ||
| 2019 | +13.19% | ||
| 2018 | -51.64% | ||
| 2017 | -42.43% | ||
| 2016 | -21.29% | ||
| 2015 | -2.29% | ||
| 2014 | +55.95% | ||
| 2013 | +108.96% | ||
| 2012 | +265.45% | ||
| 2011 | -61.27% | ||
| 2010 | -69.63% | ||
| 2009 | +34.53% | ||
| 2008 | -72.75% | ||
| 2007 | -4.32% | ||
| 2006 | +0.38% |
- Stock Market
- Equities
- NWRN Stock
- Quotes Newron Pharmaceuticals S.p.A.
